[1]袁肖肖,刘兴山,潘林康.火龙灸联合久泻方治疗脾肾阳虚型肠易激综合征临床观察[J].西部中医药,2025,38(04):139-143.[doi:10.12174/j.issn.2096-9600.2025.04.28]
　YUAN Xiaoxiao,LIU Xingshan,PAN Linkang.Clinical Observation on Fire-dragon Moxibustion and Jiuxie Decoction in the Treatment of Spleen-kidney Yang Deficiency Type of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2025,38(04):139-143.[doi:10.12174/j.issn.2096-9600.2025.04.28]
点击复制

火龙灸联合久泻方治疗脾肾阳虚型肠易激综合征临床观察()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年04期
页码:
139-143
栏目:
特色医疗
出版日期:
2025-04-15

文章信息/Info

Title:
Clinical Observation on Fire-dragon Moxibustion and Jiuxie Decoction in the Treatment of Spleen-kidney Yang Deficiency Type of Irritable Bowel Syndrome
作者:
袁肖肖1, 刘兴山2, 潘林康2
1.山东中医药大学，山东 济南 250014
2.潍坊市中医院，山东 潍坊 261000
Author(s):
YUAN Xiaoxiao1, LIU Xingshan2, PAN Linkang2
1.Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Weifang Hospital of TCM, Weifang 261000, China
关键词:
肠易激综合征; 脾肾阳虚; 火龙灸; 久泻方; 血清miR-495; 血清miR-181c-5p
Keywords:
irritable bowel syndrome; spleen-kidney deficiency; fire-dragon moxibustion; prescription; serum miR-495; miR-181c-5p
分类号:
R256.34
DOI:
10.12174/j.issn.2096-9600.2025.04.28
文献标志码:
B
摘要:
目的探讨火龙灸联合久泻方治疗脾肾阳虚型肠易激综合征（irritable bowel syndrome，IBS）的临床疗效及其对血清miR-495、miR-181c-5p表达的影响。 方法选取98例患者采取前瞻性随机对照研究，以随机数字表分为观察组和对照组，每组49例。对照组给予马来酸曲美布汀片治疗，观察组在对照组基础上给予火龙灸联合久泻方治疗，均治疗1个月。观察两组临床疗效，治疗前后证候积分、IBS生活质量（irritable bowel syndrome-quality of life，IBS-QOL）评分、内脏敏感指数（visceral sensitivity index，VSI）评分、胃肠激素水平［血清5-羟色胺（5-hydroxytryptamine，5-HT）、血管活性肠肽（vasoactive intestinal peptide，VIP）、P物质（substance P，SP）水平］、血清炎症因子水平［白细胞介素6（interleukin-6，IL-6）、白细胞介素1α（interleukin-1α，IL-1α）、超敏C反应蛋白（hypersensitive c-reactive protein，hs-CRP）］、肠道菌群数量、血清miR-495、miR-181c-5p表达水平的变化情况。 结果观察组总有效率［87.76%（43/49）］高于对照组［77.55%（38/49）］（P＜0.05）；两组治疗后证候积分、IBS-QOL评分、VSI评分、血清5-HT、VIP、IL-1α、hs-CRP、IL-6水平及肠杆菌数量较治疗前降低（P＜0.05），且观察组低于对照组（P＜0.05）；血清SP、血清miR-495、miR-181c-5p表达水平及乳杆菌数量、双歧杆菌数量均较治疗前升高（P＜0.05），且观察组高于对照组（P＜0.05）。 结论火龙灸联合久泻方治疗脾肾阳虚型IBS患者疗效显著，可改善患者生活质量，同时通过下调血清miR-495、miR-181c-5p表达，抑制血清炎症因子反应，以达到调节胃肠激素水平、调整肠道菌群目的。
Abstract:
ObjectiveTo explore clinical effects of fire-dragon moxibustion and Jiuxie (chronic diarrhea) prescription in the treatment of spleen-kidney Yang deficiency type of irritable bowel syndrome (IBS) and its influence on the expressions of serum miR-495 and miR-181c-5p. MethodsA prospective randomized controlled study was conducted on 98 patients, who were randomized into the observation group and the control group by random number table with 49 cases in each group. The control group was treated with triamterine maleate tablets, and the observation group accepted fire-dragon moxibustion and Jiuxie prescription on the foundation of the therapy the control group accepted, and both groups were treated for one month. To observe clinical effects, syndrome integrals before and after the treatment, the scores of IBS-QOL, VSI scores, the levels of gastrointestinal hormone including 5-HT, VIP and SP, the levels of serum inflammatory factors including IL-6, IL-1α and hs-CRP, the number of gut flora, the expressions of serum miR-495 and miR-181c-5p between the two groups. ResultsTotal effective rate of the observation group was [87.76%(43/49)], higher than [77.55%(38/49)] (P<0.05); syndrome integrals after the treatment, the scores of IBS-QOL, VSI scores, the levels of 5-HT and VIP, IL-1α, hs-CRP and IL-6, as well as the number of gut flora were lowered in the two groups compared with before the treatment (P<0.05), and the observation group was lower than the control group (P<0.05); the expressions of serum SP, miR-495 and miR-181c-5p, the number of Bacillus lactis and Bacillus bifidus were elevated than before the treatment (P<0.05), and the observation group was higher than the control group (P<0.05). ConclusionFire-dragon moxibustion and Jiuxie prescription could gain noticeable clinical effects in the treatment of spleen-kidney Yang deficiency type of IBS, which could improve the patients’ quality of life, meanwhile down-regulate the expressions of serum miR-495 and miR-181c-5p, inhibit the reaction of serum inflammatory factors, so as to achieve the goals of regulating the levels of gastrointestinal hormone and adjusting the gut flora.

相似文献/References:

[1]信 楠,杨培培 指导：沈舒文.健脾导滞汤治疗肠易激综合征30例[J].西部中医药,2012,25(10):91.
　XIN Nan,YANG Pei-pei Director: SHEN Shu-wen.JianPi DaoZhiTang in Treating 30 Cases of Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2012,25(04):91.
[2]周荣,彭琪,张敏.人参败毒散加味治疗腹泻型肠易激综合征 54 例[J].西部中医药,2014,27(08):52.
[3]牛立军,苏强,刘振伟,等.安肠止痛组方联合曲美布汀治疗腹泻型肠易激综合征 78 例[J].西部中医药,2014,27(08):81.
[4]张丽娜,刘则鹏,廖志峰.泻肝健脾补肾汤治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2014,27(09):120.
[5]张晓宁,马玉侠.隔药灸脐与匹维溴铵对脾虚型肠易激综合征患者尿液代谢组学影响的异同[J].西部中医药,2015,28(07):1.
[6]寇媛,赵倩,闻新丽,等.中医三联疗法治疗腹泻型肠易激综合征疗效观察[J].西部中医药,2015,28(11):79.
[7]杨磊,孙洁,李滢,等.电针对IBS模型大鼠肠系膜微血管管径与血浆CGRP、VIP水平的影响*[J].西部中医药,2014,27(03):22.
　YANG Lei,SUN Jie,LI Ying,et al.Influence of Acusector on the Levels of CGRP and VIP in the Plasma and Mesenteric Microvascular Caliber of IBS Rat Model[J].Western Journal of Traditional Chinese Medicine,2014,27(04):22.
[8]梁胜斌,杨世洁,李共信,等.敦煌葆元汤治疗肝郁脾虚型肠易激综合征的临床观察[J].西部中医药,2013,26(07):79.
　LIANG Shengbin,YANG Shijie,LI Gongxin,et al.Clinical Observation on DunHuang BaoYuanTang in Treating Irrirable Bowel Syndrome of Liver Qi Stagnation and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):79.
[9]诸凡凡,叶 柏△.腹泻型肠易激综合征发病机制及治疗现状[J].西部中医药,2013,26(10):139.
　ZHU Fanfan,YE Bai.Current State of the Treatment and Pathogenesis of Diarrhea Irritable Bowel Syndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(04):139.
[10]张亮,王玮,邱连利△.温通针法治疗脾肾阳虚型溃疡性结肠炎35例[J].西部中医药,2017,30(12):100.
　ZHANG Liang,WANG Wei,QIU Lianli.Warming Needling Method in Treating 35 Cases of Ulcerative Colitis of Spleen-kidney Yang-deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2017,30(04):100.
[11]张伟健,黄彦子,陈新博,等.郭绍举主任运用水湿内停方治疗肠易激综合征的经验[J].西部中医药,2022,35(03):57.[doi:10.12174/j.issn.2096-9600.2022.03.13]
　ZHANG Weijian,HUANG Yanzi,CHEN Xinbo,et al.Director Guo Shaoju’s Experience in Treating Diarrhea-predominant Irritable Bowel Disease by Water-damp Internal Retention Prescription[J].Western Journal of Traditional Chinese Medicine,2022,35(04):57.[doi:10.12174/j.issn.2096-9600.2022.03.13]

备注/Memo

备注/Memo:
袁肖肖（1995—），女，硕士学位。研究方向：中西医结合治疗脾胃病的临床研究。山东省中医药科技发展计划项目（2019-0708）。
更新日期/Last Update: 2025-04-15